PI11549 (Benzothiazol-2-yl)-(Z)-2-trityloxyimino-2-(2-aminothiazole-4-yl)-thioacetate (CAS No.: 143183-03-3)

(Benzothiazol-2-yl)-(Z)-2-trityloxyimino-2-(2-aminothiazole-4-yl)-thioacetate (CAS No.: 143183-03-3) Description

This chemical intermediate, with the molecular formula C31H22N4O2S3, is utilised in complex organic synthesis for pharmaceutical applications. Its structure supports targeted functional group transformations and controlled reaction pathways. The powdered form facilitates uniform mixing in bulk synthesis, aiding reproducibility in reaction setups. Technical analysis via chromatographic and spectroscopic methods confirms its identity and purity, ensuring its suitability in compound development.

(Benzothiazol-2-yl)-(Z)-2-trityloxyimino-2-(2-aminothiazole-4-yl)-thioacetate (CAS No.: 143183-03-3) Applications

1.         Pharmaceutical Synthesis
- Used as an intermediate in synthetic routes to achieve specific molecular modifications by leveraging its defined reactive centres.
- Applied as a reagent in compound formulation to facilitate bond formation through controlled reactivity.

2.         Organic Research
- Employed in laboratory settings as a model compound for evaluating reaction mechanisms, taking advantage of its known structural characteristics.
- Utilised in method development to optimise synthesis steps in academic and industrial research.

(Benzothiazol-2-yl)-(Z)-2-trityloxyimino-2-(2-aminothiazole-4-yl)-thioacetate (CAS No.: 143183-03-3) Packing

The product is packaged in airtight, moisture-resistant containers lined with inert materials to avoid contamination. Storage recommendations include ambient temperature and low-humidity conditions to prevent degradation. Anti-contamination measures such as sealed pouches and desiccant inserts are employed during packaging. Custom packaging solutions are available to suit specific sample sizes and handling requirements upon inquiry.

Additional Information

Pharmaceutical intermediates such as this compound play a crucial role in synthesising complex organic molecules. Their precise molecular architecture is critical for facilitating specific chemical transformations in drug development. Understanding the reactivity patterns of such intermediates allows researchers to design targeted synthesis processes with improved efficiency.

In the broader context, the development of advanced intermediates has developed organic synthesis methodologies. Detailed characterisation using modern analytical instruments supports process optimisation, ensuring that each batch conforms to the expected chemical profile and functional performance during production.